Literature DB >> 25809817

Repair of spinal cord injury by chitosan scaffold with glioma ECM and SB216763 implantation in adult rats.

Rao Jian1, Yang Yixu1, Lin Sheyu2, Shen Jianhong1, Yan Yaohua1, Su Xing1, Huang Qingfeng1, Lu Xiaojian1, Zhang Lei1, Zhen Yan1, Xiong Fangling1, Gao Huasong3, Gao Yilu1.   

Abstract

The loss of spinal cord tissue and the cavity formation are major obstacles to the repair of spinal cord injury (SCI). In the study, the scaffold of chitosan+ECM+SB216763 was fabricated and used for the repair of injured spinal cord injury. First, the biocompatibility of the scaffold was analyzed and results showed that the scaffold had a good compatibility with the neural stem cells. Especially, the processes of differentiated neural stem cell embedded in the scaffold were found in the experiment. At the same time, we also investigated the effect of scaffold on the differentiation of neural stem cell. The results showed that the scaffold of chitosan+ECM+SB216763 could significantly promote the differentiation of neural stem cells into neurons, astrocytes, and oligodendrocytes relative to those in other groups. In order to probe the application of scaffold in vivo, the rat models of spinal cord hemisection were set up and scaffolds were implanted into transected gap. Then the electrophysiology and BBB score were evaluated and results showed that the amplitude, latency period and BBB score in chitosan+ECM+SB216763 group were dramatically better than those in other groups. In addition, the differentiation of neural stem cells into nerve cells was also assayed and the results revealed that the number of neural stem cells differentiating into neuron, astrocytes and oligodendrocytes in chitosan+ECM+SB216763 group was significantly bigger than those in other groups. All these data suggested that the scaffold of chitosan+ECM+SB216763 would be a promising medium for the repair of injured spinal cord.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ECM; SB216763; SCI; neural stem cells

Mesh:

Substances:

Year:  2015        PMID: 25809817     DOI: 10.1002/jbm.a.35466

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  9 in total

1.  Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture.

Authors:  Liyang Gao; Mingyan Zhao; Peng Li; Junchao Kong; Zhijun Liu; Yonghua Chen; Rui Huang; Jiaqi Chu; Juanhua Quan; Rong Zeng
Journal:  Hum Cell       Date:  2016-09-07       Impact factor: 4.174

2.  Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats.

Authors:  Mahdi Gholami; Hassan Gilanpour; Javad Sadeghinezhad; Ahmad Asghari
Journal:  Daru       Date:  2021-09-07       Impact factor: 4.088

3.  Phenotypes of Motor Deficit and Pain after Experimental Spinal Cord Injury.

Authors:  Volodymyr Krotov; Volodymyr Medvediev; Ibrahim Abdallah; Arseniy Bozhenko; Mykhailo Tatarchuk; Yevheniia Ishchenko; Leonid Pichkur; Serhii Savosko; Vitaliy Tsymbaliuk; Olga Kopach; Nana Voitenko
Journal:  Bioengineering (Basel)       Date:  2022-06-20

4.  Efficacy of chitosan and sodium alginate scaffolds for repair of spinal cord injury in rats.

Authors:  Zi-Ang Yao; Feng-Jia Chen; Hong-Li Cui; Tong Lin; Na Guo; Hai-Ge Wu
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

5.  The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration.

Authors:  Rosaliana Libro; Placido Bramanti; Emanuela Mazzon
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

Review 6.  The combination of induced pluripotent stem cells and bioscaffolds holds promise for spinal cord regeneration.

Authors:  Ashley DeBrot; Li Yao
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

Review 7.  Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong; Wai Yee Chan
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

8.  Bridging the lesion-engineering a permissive substrate for nerve regeneration.

Authors:  Liliana R Pires; Ana P Pêgo
Journal:  Regen Biomater       Date:  2015-08-10

9.  Biocompatibility of reduced graphene oxide nanoscaffolds following acute spinal cord injury in rats.

Authors:  Ali H Palejwala; Jared S Fridley; Javier A Mata; Errol L G Samuel; Thomas G Luerssen; Laszlo Perlaky; Thomas A Kent; James M Tour; Andrew Jea
Journal:  Surg Neurol Int       Date:  2016-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.